Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

liquid biopsy

  • You have access
    Exploring the Clinical Significance of Circulating H19 lncRNA and IGF-2 mRNA in Colorectal Carcinoma
    MIRAY ÇIFTÇI, EMRE ÖZGÜR, CEMIL BURAK KULLE, UGUR GEZER and EBRU ESIN YÖRÜKER
    Anticancer Research October 2025, 45 (10) 4243-4251; DOI: https://doi.org/10.21873/anticanres.17775
  • You have access
    Prediction System for KRAS Mutation Detection in Circulating Tumor DNA in Unresectable Pancreatic Cancer
    HIROSHI SHIMIZU, REI SUZUKI, HIROYUKI ASAMA, MITSURU SUGIMOTO, KENTARO SATO, KENTO OSAWA, REI OHIRA and HIROMASA OHIRA
    Anticancer Research September 2025, 45 (9) 3931-3938; DOI: https://doi.org/10.21873/anticanres.17751
  • Open Access
    Comparison of Comprehensive Genomic Profiling Testing “Ion Torrent Genexus Sequencer” With FoundationOne
    KENJI FUJIYOSHI, RIE SUGIHARA, NAOKI MIYAMOTO, YORIKO WATANABE, TOMOYA SUDO, SANAE NUMATA, JUN AKIBA, HIDEYUKI ABE, YUKA ICHINOSE, KENJI INOUE, SHUICHI OZONO, TAKEHARU ONO, KENTARO ORIOKA, MASAKI KASHIHARA, RYOUSUKE KAJIWARA, HIROYUKI KAWANO, AKIHIKO KAWAHARA, RYUTA TAKASE, UHI TOH, KAZUAKI HASHIMOTO, TORU HISAKA, SHINGO HIRAI, MASAHIRO MITSUOKA, DAIKI MIYAZAKI, FUMI YOSHITOMI, KEN YAMAMOTO, HIROHITO UMENO, MASAHISA NOMURA and YOSHIKI NAITO
    Anticancer Research August 2025, 45 (8) 3479-3486; DOI: https://doi.org/10.21873/anticanres.17709
  • Open Access
    Circulating Tumor DNA Methylation Is a Biomarker of Poor Recurrence-free Survival in Locally-Advanced Rectal Cancer
    KIICHI SUGIMOTO, TAKAHIRO IRIE, HIROTAKA MOMOSE, SAKI KOCHI, MIYUKI TOAKE, YUKI TSUCHIYA, RYOICHI TSUKAMOTO, KUMPEI HONJO, SHUN ISHIYAMA, MAKOTO TAKAHASHI, ROBERT M. HOFFMAN and KAZUHIRO SAKAMOTO
    Anticancer Research April 2025, 45 (4) 1559-1573; DOI: https://doi.org/10.21873/anticanres.17537
  • You have access
    Circulating Pre-microRNA-488 in Blood Is a Potential Prognostic Biomarker in Gastric Cancer
    YUSUKE TSURUDA, TAKAAKI MASUDA, YOSHIKI HIRAKI, MIWA KITAGAWA, DAI SHIMIZU, QINGJIANG HU, SHUHEI ITO, HAJIME OTSU, YOSUKE KURODA, HIDETOSHI EGUCHI, TAKAO OHTSUKA, SHOJI NATSUGOE and KOSHI MIMORI
    Anticancer Research January 2025, 45 (1) 123-133; DOI: https://doi.org/10.21873/anticanres.17399
  • You have access
    Copy Number Gain in Androgen Receptors Predicts the Poor Prognosis in Japanese Castration-resistant Prostate Cancer
    SHINICHI SAKAMOTO, KEISUKE ANDO, SANGJON PAE, XUE ZHAO, KAZUKO SAKAI, KODAI SATO, SHINPEI SAITO, YASUTAKA YAMADA, JUNRYO RII, YUSUKE GOTO, TOMOKAZU SAZUKA, YUSUKE IMAMURA, NAOHIKO ANZAI, KOICHIRO AKAKURA, KAZUTO NISHIO and TOMOHIKO ICHIKAWA
    Anticancer Research February 2024, 44 (2) 639-647; DOI: https://doi.org/10.21873/anticanres.16853
  • Open Access
    Multi-gene Liquid Biopsy to Detect Resistance to First-line Osimertinib in Patients With EGFR-mutated Lung Adenocarcinoma
    SHIN ITO, KYOJI TSURUMI, NORIHISA SHINDO, SATOSHI SOMA, KAZUNORI YAMAGUCHI, KEIICHI TAMAI, MAI MOCHIZUKI, HARUNA FUJIMORI, MAMI MORITA, KANA WATANABE, AYA SUZUKI, TATSURO FUKUHARA and JUN YASUDA
    Anticancer Research November 2023, 43 (11) 5031-5040; DOI: https://doi.org/10.21873/anticanres.16702
  • You have access
    Tumor DNA in Peritoneal Lavage as a Novel Biomarker for Predicting Peritoneal Recurrence in Patients With Gastric Cancer
    NORIO YUKAWA, TAKESHI YAMADA, TORU AOYAMA, TEKKAN WOO, KOJI UEDA, AKIHISA MASTUDA, KENTARO HARA, KEISUKE KAZAMA, HIROSHI TAMAGAWA, TSUTOMU SATO, TAKASHI OSHIMA, AKIHIRO SUZUKI, HIROYUKI ABURATANI, SHUMPEI ISHIKAWA, AYA SAITO, MUNETAKA MASUDA, HIROSHI YOSHIDA and YASUSHI RINO
    Anticancer Research May 2023, 43 (5) 2069-2076; DOI: https://doi.org/10.21873/anticanres.16367
  • You have access
    Preoperative Plasma miRNA Levels Predict Prognosis in Early-stage Malignant Melanoma
    MAHYAR SHARIF BAGHERI, JIRI POLIVKA, INKA TRESKOVA, KATERINA HOUFKOVA, TEREZA KNIZKOVA, VLASTIMIL WOZNICA, TOMAS FIKRLE, KRISTYNA PIVOVARCIKOVA, MARTIN SVATON, DATTATRYA SHETTI, RASHMI NEGI and MARTIN PESTA
    Anticancer Research February 2023, 43 (2) 695-706; DOI: https://doi.org/10.21873/anticanres.16208
  • Open Access
    Diagnosing and Prognosing Bone Metastasis in Prostate Cancer: Clinical Utility of Blood Biomarkers
    GAKU YAMAMICHI, TAIGO KATO, MOTOHIDE UEMURA and NORIO NONOMURA
    Anticancer Research January 2023, 43 (1) 283-290; DOI: https://doi.org/10.21873/anticanres.16161

Pages

  • Next
  • 1
  • 2
  • 3
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire